Combination of the Kdm-Family Inhibitor, Jib-04, Improves Response to Acute Myeloid Leukemia Cells to Venetoclax

被引：0
|
作者：
Wohlan, Katharina [1 ]
Fan, Dandan [2 ,3 ,4 ,5 ]
Guzman, Anna [1 ]
Su, Jianzhong [2 ,3 ,4 ,5 ]
Goodell, Margaret A. [1 ,6 ,7 ]
Rau, Rachel E. [6 ,7 ]
机构：
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Wenzhou Med Univ, Inst Biomed Big Data, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Sch Biomed Engn, Wenzhou, Peoples R China
[4] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China
[5] Wenzhou Med Univ, Eye Hosp, Wenzhou, Peoples R China
[6] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA
[7] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-160199
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5953 / 5954
页数：2
相关论文
共 50 条
  • [1] SOS1 inhibitor treatment improves response to Venetoclax in acute myeloid leukemia
    Kostyrko, Kaja
    Hinkel, Melanie
    Rees, Matthew G.
    Ronan, Melissa M.
    Roth, Jennifer A.
    Gerlach, Daniel
    Waizenegger, Irene
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Timing of response to venetoclax combination treatment in older patients with acute myeloid leukemia.
    Jonas, Brian Andrew
    Dinardo, Courtney Denton
    Pratz, Keith
    Wei, Andrew
    Hong, Wan-Jen
    Chyla, Brenda
    Duan, Yinghui
    Potluri, Jalaja
    Werner, Michael
    Pollyea, Daniel Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
    Jonas, Brian A.
    Wei, Andrew H.
    Recher, Christian
    DiNardo, Courtney D.
    Jang, Jun-Ho
    Pratz, Keith
    Panayiotidis, Panayiotis
    Montesinos, Pau
    Yeh, Su-Peng
    Ivanov, Vladimir
    Fiedler, Walter
    Yamauchi, Takahiro
    Duan, Yinghui
    Mendes, Wellington
    Potluri, Jalaja
    Tews, Bjorn
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E299 - E303
  • [4] Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML).
    Dinardo, Courtney Denton
    Pratz, Keith William
    Potluri, Jalaja
    Pullarkat, Vinod A.
    Jonas, Brian Andrew
    Wei, Andrew H.
    Becker, Pamela Sue
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel Aaron
    Letai, Anthony G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [6] A Novel BTK Inhibitor Induces Cells Death and Enhances the Efficacies of Venetoclax in Acute Myeloid Leukemia Cells
    Schmalbach, Nicole K.
    Al-Odat, Omar S.
    Elbezanti, Weam
    Yao, Gabriella
    Guirguis, Daniel A.
    Gowda, Krishne
    Amin, Shantu G.
    Budak-Alpdogan, Tulin
    Jonnalagadda, Subash C.
    Pandey, Manoj Kumar
    BLOOD, 2022, 140 : 12998 - 12998
  • [7] Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed/Refractory Acute Myeloid Leukemia
    Yu, Guopan
    Xu, Na
    Huang, Fen
    Fan, Zhiping
    Liu, Hui
    Shi, Pengcheng
    Zhou, Hongsheng
    Wang, Zhixiang
    Zhang, Yu
    Liu, Qifa
    BLOOD, 2020, 136
  • [8] Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
    Waclawiczek, Alexander
    Leppae, Aino-Maija
    Renders, Simon
    Stumpf, Karolin
    Reyneri, Cecilia
    Betz, Barbara
    Janssen, Maike
    Shahswar, Rabia
    Donato, Elisa
    Karpova, Darja
    Thiel, Vera
    Unglaub, Julia M.
    Grabowski, Susanna
    Gryzik, Stefanie
    Vierbaum, Lisa
    Schlenk, Richard F.
    Roellig, Christoph
    Hundemer, Michael
    Pabst, Caroline
    Heuser, Michael
    Raffel, Simon
    Mueller-Tidow, Carsten
    Sauer, Tim
    Trumpp, Andreas
    CANCER DISCOVERY, 2023, 13 (06) : 1408 - 1427
  • [9] COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX
    Waclawiczek, A.
    Leppa, A.
    Renders, S.
    Stumpf, K.
    Reyneri, C.
    Betz, B.
    Janssen, M.
    Shahswar, R.
    Donato, E.
    Unglaub, J. M.
    Schlenk, R. F.
    Hundemer, M.
    Pabst, C.
    Heuser, M.
    Raffel, S.
    Mueller-Tidow, C.
    Sauer, T. .
    Trumpp, A.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S45 - S45
  • [10] Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
    DiNardo, Courtney D.
    Rausch, Caitlin R.
    Benton, Christopher
    Kadia, Tapan
    Jain, Nitin
    Pemmaraju, Naveen
    Daver, Naval
    Covert, Wendy
    Marx, Kayleigh R.
    Mace, Morgan
    Jabbour, Elias
    Cortes, Jorge
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Bhalla, Kapil N.
    Kantarjian, Hagop
    Konopleva, Marina
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (03) : 401 - 407
12345